Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multi-Institutional Study of Low-Dose (2Gy) Palliative Radiotherapy in the Treatment of Symptomatic Bone Metastases From Multiple Myeloma

NCT03858205 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT03858205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03858205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multi-Institutional Study of Low-Dose (2Gy) Palliative Radiotherapy in the Treatment of Symptomatic Bone Metastases From Multiple Myeloma
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Recruiting
Start date
March 11, 2019
Completion date
March 11, 2027
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bone pain, metastatic malignant neoplasm in the bone, plasma cell myeloma